Alnylam Pharmaceuticals | ALNY - PE Price to Earnings

Stock Price
320.42
Daily Change
1.51 0.47%
Monthly
-3.69%
Yearly
31.16%
Q1 Forecast
303.95

Alnylam Pharmaceuticals reported 170.7 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 16.05 2.92 Sep/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Sanofi 15.75 1.53 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Takeda 235.05 184.95 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Xencor 29.92 3.22 Sep/2022